Regenerative Medicine Market Its Application and Types 2030 : Novartis AG, Integra LifeSciences Corporation, Vericel Corporation,
In recent years, prevalence and incidences of chronic infectious diseases as well as genetic disorders is increasing the growth of Regenerative Medicine. According to the report, the global regenerative medicine market was estimated to be over US$ 13 billion in 2019. It is anticipated to grow at a CAGR of 23.2% from 2019 to 2030.
View full press release